Janux’s pipeline expansion into autoimmune disease, new immune-oncology product candidates, and over 6-year cash runway ...

Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune ...

Prasad’s short FDA tenure brought stricter review standards for gene and COVID vaccines, sparking biotech concern and political backlash.

As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...

Lab grown models of embryos, made from clusters of stem cells, are getting increasingly complex. Ethicists, regulators and ...

Vinay Prasad, M.D., has left the FDA less than three months into the role as director of the Center for Biologics Evaluation ...

The field of immunology has long been focused on understanding the complex interactions between the immune system and ...

A deal with US WorldMeds includes the FDA-approved TCR therapy Tecelra and two clinical-stage cancer medicines.

Table of Contents The Hidden Power of Epigenetic Nutrition Programming Why Timing Your Meals Like a Circadian Clock Changes Everything […] The post Pregnancy Diet Meal Plan: The Science-Backed ...

She repeatedly denied that it was her intention to circumvent either Freedom of Information or ex parte rules.

Dr. Folashade Otegbeye, facility director of the Therapeutic Products Program at Fred Hutch, works to rapidly translate what ...

PD-1 treatment may help by shifting certain immune cells to fight diseases like kidney cancer; higher CD163-positive TAMs are linked to better outcomes.